These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2307730

  • 1. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism.
    Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):766-70. PubMed ID: 2307730
    [Abstract] [Full Text] [Related]

  • 2. Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.
    Wakasugi M, Wakao R, Tawata M, Gan N, Inoue M, Koizumi K, Onaya T.
    Thyroid; 1994 Mar; 4(2):179-82. PubMed ID: 7920000
    [Abstract] [Full Text] [Related]

  • 3. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry.
    Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T.
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):283-6. PubMed ID: 8096166
    [Abstract] [Full Text] [Related]

  • 5. [Serum osteocalcin in hyperthyroidism].
    Roiter I, Legovini P, Da Rin G, Galliazzo S, Di Virgilio R, Foscolo G, Breda F, Conte N.
    Ann Ital Med Int; 1990 Mar; 5(2):95-9. PubMed ID: 2248865
    [Abstract] [Full Text] [Related]

  • 6. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
    Chai R, Ye Z, Zhan Z.
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
    [Abstract] [Full Text] [Related]

  • 7. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 8. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
    Christ E, Linka A, Junga G, Odermatt M, Steinert H, Kiowski W, Schmid C.
    Schweiz Med Wochenschr; 1996 Sep 14; 126(37):1553-9. PubMed ID: 8927958
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
    Young NR, Baker HW, Liu G, Seeman E.
    J Clin Endocrinol Metab; 1993 Oct 14; 77(4):1028-32. PubMed ID: 8408450
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.
    Horm Metab Res; 1995 Nov 14; 27(11):503-7. PubMed ID: 8770627
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C, Golia F, Vignali E, Pinchera A.
    J Bone Miner Res; 1997 Jan 14; 12(1):72-7. PubMed ID: 9240728
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.